Bio-Techne (NASDAQ:TECH) Earns Overweight Rating from Analysts at Wells Fargo & Company
Research analysts at Wells Fargo & Company began coverage on shares of Bio-Techne (NASDAQ:TECH – Get Free Report) in a report released on Friday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $59.00 price target on the biotechnology company’s stock. Wells Fargo & Company‘s target price suggests a potential upside of 21.90% […]
